Akoya Biosciences (NASDAQ:AKYA) and The University of Queensland's Frazer Institute have published a study in GEN Biotechnology that used ultrahigh-plex spatial phenotyping to map the spatial proteome of head and neck squamous cell carcinoma (HNSCC). The study identified a high degree of intra- and inter-tumoral heterogeneity intrinsic to head and neck cancers. The analysis was conducted using Akoya's PhenoCycler-Fusion system, which is the fastest spatial biology solution available.